Grants per year
Personal profile
Research Interests
The Division of Immunotherapy and Autoimmune Diseases (DIAD) is the only center in the world devoted to a unique area of treatment and research utilizing stem cell transplantation in clinical trials for autoimmune diseases and vascular diseases. DIAD pioneered and performed America’s first hematopoietic stem cell transplants to treat: Multiple Sclerosis (MS), Diabetes, Lupus, Crohn’s, Rheumatoid Arthritis, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Phemphigus, Dermatomyositis, Devic’s, Myasthenia Gravis, Polymositis and Scleroderma
Certifications and Licenses
| Internal Medicine | |
| Hematology/Oncology |
Training Experience
| 1987 | Residency, Baylor Affiliated Hospitals |
| 1993 | Fellowship, National Institutes of Health |
Education/Academic qualification
MD, Saint Louis University
… → 1984
Research interests
- Autoimmune Diseases
- Vascular Biology
Fingerprint Dive into the research topics where Richard K Burt is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 10 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants
- 14 Finished
Stem Cell Transplantation for Autoimmune Diseases
Northwestern Memorial Hospital, Illinois Department of Healthcare and Family Services
9/1/12 → 8/31/15
Project: Research project
Hematopoietic Stem Cell Transplantation for Autoimmune Hepatitis
Masimo Foundation for Ethics, Innovation, and Competition in Healthcare
1/1/12 → 12/31/12
Project: Research project
Peptide Vaccine Suppressing Autoantigen-Specific Response in Human Lupus
Burt, R. K., Datta, S. K. & Zhang, L.
4/1/11 → 9/30/14
Project: Research project
Hematopoietic Stem Cell Transplantation Induces Remission in Lupus
Lupus Foundation of America, Inc.
2/1/10 → 9/30/12
Project: Research project
Research Output
A pilot feasibility study of non-myeloablative allogeneic hematopoietic stem cell transplantation for refractory Crohn Disease
Burt, R. K., Craig, R., Yun, L., Halverson, A. L., Quigley, K., Arnautovic, I. & Han, X., Jan 1 2020, (Accepted/In press) In : Bone Marrow Transplantation.Research output: Contribution to journal › Letter
Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica
Burt, R. K., Balabanov, R., Han, X., Burns, C., Gastala, J., Jovanovic, B., Helenowski, I., Jitprapaikulsan, J., Fryer, J. P. & Pittock, S. J., Oct 29 2019, In : Neurology. 93, 18, p. E1732-E1741Research output: Contribution to journal › Article
4
Scopus
citations
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial
Burt, R. K., Balabanov, R., Burman, J., Sharrack, B., Snowden, J. A., Oliveira, M. C., Fagius, J., Rose, J., Nelson, F., Barreira, A. A., Carlson, K., Han, X., Moraes, D., Morgan, A., Quigley, K., Yaung, K., Buckley, R., Alldredge, C., Clendenan, A., Calvario, M. A. & 3 others, , Jan 15 2019, In : JAMA - Journal of the American Medical Association. 321, 2, p. 165-174 10 p.Research output: Contribution to journal › Article
48
Scopus
citations
Five year follow-up after autologous peripheral blood hematopoietic stem cell transplantation for refractory, chronic, corticosteroid-dependent systemic lupus erythematosus: Effect of conditioning regimen on outcome
Burt, R. K., Han, X., Gozdziak, P., Yaung, K., Morgan, A., Clendenan, A. M., Henry, J., Calvario, M. A., Datta, S. K., Helenowski, I. & Schroeder, J., Jun 1 2018, In : Bone Marrow Transplantation. 53, 6, p. 692-700 9 p.Research output: Contribution to journal › Article
10
Scopus
citations
News & views: Autologous HSCT is efficacious, but can we make it safer?
Burt, R. K. & Farge, D., Mar 21 2018, In : Nature Reviews Rheumatology. 14, 4, p. 189-191 3 p.Research output: Contribution to journal › Article
7
Scopus
citations